| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $17.9M | -20.8% |
| R&D Expense | $4.6M | -18.8% |
| SG&A Expense | $11.7M | -20.2% |
| Operating Income | -$8.0M | +59.1% |
| Pre-tax Income | -$10.2M | +45.8% |
| Income Tax | $0 | +100.0% |
| Net Income | -$10.2M | +45.7% |
| EPS (Basic) | -$2.53 | -666.7% |
| EPS (Diluted) | -$2.53 | -666.7% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | -31.6% |
| Accounts Receivable | $1.6M | -62.6% |
| Current Assets | $5.8M | -34.6% |
| Total Assets | $35.6M | -14.8% |
| Current Liabilities | $23.1M | +68.6% |
| Total Liabilities | $23.3M | +1.7% |
| Stockholders' Equity | $12.3M | -34.7% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | +31.6% |
| Capital Expenditures | $7K | -87.0% |
| Investing Cash Flow | -$858K | +47.1% |
| Financing Cash Flow | $1.4M | +218.9% |
| Free Cash Flow | -$1.5M | +33.0% |